Times Square Capital Management, LLC Vertex Pharmaceuticals Inc Transaction History

Times Square Capital Management, LLC

$6.49 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$181.39 - $202.99 $574,099 - $642,463	-3,165 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$187.49 - $221.1 $37,498 - $44,220	200 Added 6.75%	3,165 $638,000
Q1 2021 May 12, 2021	BUY	$207.02 - $241.31 $94,194 - $109,796	455 Added 18.13%	2,965 $637,000
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $87,979 - $117,338	-425 Reduced 14.48%	2,510 $593,000
Q3 2020 Nov 06, 2020	SELL	$255.65 - $303.1 $3.46 Million - $4.11 Million	-13,550 Reduced 82.2%	2,935 $799,000
Q2 2020 Aug 07, 2020	SELL	$225.48 - $295.8 $100 Million - $131 Million	-443,855 Reduced 96.42%	16,485 $4.79 Million
Q1 2020 May 08, 2020	SELL	$199.77 - $247.81 $4.3 Million - $5.34 Million	-21,530 Reduced 4.47%	460,340 $110 Million
Q4 2019 Feb 05, 2020	SELL	$166.71 - $223.91 $22.2 Million - $29.9 Million	-133,350 Reduced 21.68%	481,870 $106 Million
Q3 2019 Nov 05, 2019	BUY	$166.23 - $187.09 $17.5 Million - $19.7 Million	105,030 Added 20.59%	615,220 $104 Million
Q2 2019 Aug 02, 2019	SELL	$164.61 - $190.37 $1.74 Million - $2.02 Million	-10,585 Reduced 2.03%	510,190 $93.6 Million
Q1 2019 May 10, 2019	BUY	$163.73 - $194.7 $8.16 Million - $9.71 Million	49,855 Added 10.59%	520,775 $95.8 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $12.8 Million - $16.2 Million	-84,160 Reduced 15.16%	470,920 $78 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $21.6 Million - $24.8 Million	-128,730 Reduced 18.83%	555,080 $0
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $23.8 Million - $27.8 Million	163,480 Added 31.42%	683,810 $116 Million
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $502,554 - $587,185	3,315 Added 0.64%	520,330 $84.8 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $7.05 Million - $7.98 Million	51,325 Added 11.02%	517,015 $77.5 Million
Q3 2017 Nov 09, 2017	SELL	$148.13 - $162.24 $3.65 Million - $4 Million	-24,655 Reduced 5.03%	465,690 $70.8 Million
Q2 2017 Aug 10, 2017	BUY	N/A	490,345	490,345 $63.2 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.5 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.89 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.29 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Times Square Capital Management, LLC with notifications on news.

Account